|Immunogen||Influenza A/Puerto Rico/8/34(H1N1) and A/Bangkok/1/79 (H3N2) Viruses.|
|Purification||>90% pure (SDS-PAGE). Protein A Chromatography|
|Target/Specificity||Recognizes the Influenza A matrix protein.|
|Preservative||0.09% Sodium Azide|
|Storage||Short-term (up to 2 weeks) store at 2-8°C. Long term store at -20°C. Avoid multiple freeze/thaw cycles.|
|Precautions||Monoclonal Antibody to Influenza A (matrix Protein) [GA2B] is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only.1. Chiang, C., et al., (2008), “Mutations at Alternative 5’ splice sites of Ml mRNA negatively affect Influenza A Virus viability and growth rate”, Journal of Virology, 82(21): 10873-108862. Hui, E.K.W., et al., (2006), “Mutations in Influenza Virus Ml CCHH, the Putative Zinc Finger Motif, Cause Attenuation in Mice and Protect Mice against Lethal Influenza Virus Infection”, Journal of Virology, 80(12): 569757073. Latham, T., et al., (2001), “Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins”, J. Virol., 75 (13): 6154-6165.
If you have any additional inquiries please email technical services at email@example.com.